Design Therapeutics, Inc. DSGN
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Design Therapeutics Inc. is a biotechnology company focused on developing treatments for serious degenerative disorders. At the heart of its operations is the use of a proprietary technology platform aimed at addressing the underlying genetic causes of such conditions. Design Therapeutics specializes in creating what t…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees54
TickerDSGN
Statistics
Market Cap$741.5M
Revenue (TTM)$0
Net Income-$69.8M
Net Margin—
EPS$-1.22
P/E-9.01
P/S—
P/B3.02
EV/EBITDA-5.63
ROE-31.3%
Dividend Yield—
Price$11.88
Data: Twelve Data · Revenue = mcap / P/S